3
Announcements
Trials
Browse
Landscape
Status
Recruiting
10
Unknown
3
Active not recruiting
3
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
2
Multiple Myeloma
2
Lymphoma
2
Burkitt Lymphoma
2
Pancreatic Neoplasms
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia
1
Carcinoma, Pancreatic Ductal
1
Interventions
Cyclophosphamide
10
Rituximab
9
polatuzumab vedotin
6
Prednisone
6
Doxorubicin
6
Vincristine
5
zanubrutinib
4
glofitamab
4
Prednisolone
4
Lenalidomide
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Lisaftoclax
3
tafasitamab
2
obinutuzumab
2
fludarabine
2
Radiotherapy
2
R-CHOP protocol
2
Observation
2
venetoclax
1
sintilimab
1
resiniferatoxin
1
penpulimab
1
pegfilgrastim
1
orelabrutinib
1
loncastuximab tesirine
1
duvelisib
1
acalabrutinib
1
Vancomycin
1
Therapeutics
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Lymphoma, Large B-Cell, Diffuse
×
Immunotherapy, Adoptive
×
Clear all
NCT07463781
2026-03-13
NEURO_CAR-T
Fondazione Italiana Linfomi - ETS
Not yet recruiting
100 enrolled